levodopa has been researched along with Neuroblastoma in 33 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (21.21) | 18.7374 |
| 1990's | 8 (24.24) | 18.2507 |
| 2000's | 7 (21.21) | 29.6817 |
| 2010's | 8 (24.24) | 24.3611 |
| 2020's | 3 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Fujita, K; Inoue, S; Ito, S; Yamamoto, Y | 1 |
| Eriksson, H; Rössler, OG; Thiel, G | 1 |
| Bhuvanendran, S; Magalingam, KB; Radhakrishnan, AK; Ramdas, P; Selvaduray, KR; Somanath, SD | 1 |
| Haertlé, T; Jafarkhani, S; Meratan, AA; Muronetz, V; Saboury, AA; Zohoorian-Abootorabi, T | 1 |
| Choi, SM; Kim, BC; Nguyen, DT; Samidurai, M; Song, J | 1 |
| Abdullah, R; Basak, I; Larsen, JP; Lee, S; Møller, SG; Patil, KS | 1 |
| Ji, C; Liu, Y; Ren, Z; Wang, T; Yang, N; Zheng, J; Zuo, P | 1 |
| Davidson, DF; Dow, E; Kelly, AU; Srivastava, R | 1 |
| Feng, LR; Maguire-Zeiss, KA | 1 |
| Arning, E; Bottiglieri, T; Nunbhakdi-Craig, V; Sontag, E; Sontag, JM; Wasek, B | 1 |
| Colamartino, M; Cornetta, T; Cozzi, R; Leone, S; Meneghini, C; Padua, L; Testa, A | 1 |
| Ho, A; Peritore, CS; Schaus, SE; Yamamoto, BK | 1 |
| Asanuma, M; Emdadul Haque, M; Higashi, Y; Miyazaki, I; Ogawa, N; Tanaka, K | 1 |
| Jankovic, J; Le, W; Pan, T | 1 |
| Benghuzzi, H; Martin, TM; Tucci, M | 2 |
| Giasson, BI; Ischiropoulos, H; Lynch, DR; Mazzulli, JR; Mishizen, AJ; Nagatsu, T; Nakashima, A; Ota, A; Thomas, SA | 1 |
| Fujita, K; Inoue, S; Ito, S | 1 |
| de Yébenes, JG; Mena, MA; Pardo, B | 1 |
| Fahn, S; García de Yébenes, J; Mena, MA; Pardo, B | 1 |
| Lai, CT; Yu, PH | 2 |
| Appel, SH; Jankovic, J; Le, W; Rowe, DB; Xie, W; Zou, L | 1 |
| Sampaio-Maia, B; Soares-da-Silva, P | 1 |
| Canals, S; Casarejos, MJ; de Bernardo, S; Handler, A; Mena, MA; Rodríguez-Martín, E | 1 |
| de Vries, JA; Fremouw-Ottevangers, DC; Muskiet, FA; van der Meulen, J; Wolthers, BG | 1 |
| Wick, MM | 1 |
| de Vries, JA; Fremouw-Ottevangers, DC; Muskiet, FA; Nagel, GT; Wolthers, BG | 1 |
| Casarejos, MJ; Fahn, S; García de Yébenes, J; Mena, MA; Pardo, B | 1 |
| Bartsch, O; Busse, E; Kornhuber, B | 1 |
| Darchen, F; Henry, JP; Horellou, P; Mallet, J; Marlier, L; Privat, A; Scherman, D | 1 |
| Abeling, NG; Overmars, H; van Gennip, AH; Voûte, PA | 1 |
| McGrath, PC; Neifeld, JP | 1 |
33 other study(ies) available for levodopa and Neuroblastoma
| Article | Year |
|---|---|
Synthesis and antitumor activity of cysteinyl-3,4-dihydroxyphenylalanines and related compounds.
Topics: Animals; Antineoplastic Agents; Cell Division; Cell Line; Cricetinae; Cysteinyldopa; Dihydroxyphenylalanine; Humans; Leukemia L1210; Male; Melanoma; Mice; Neoplasms, Experimental; Neuroblastoma | 1981 |
Tyrosine hydroxylase gene promoter activity is upregulated in female catecholaminergic neuroblastoma cells following activation of a Gαq-coupled designer receptor.
Topics: Calcineurin; Chromatin; EGF Family of Proteins; Extracellular Signal-Regulated MAP Kinases; Female; GTP Phosphohydrolases; GTP-Binding Proteins; Histone Acetyltransferases; Humans; Levodopa; Nerve Growth Factors; Neuroblastoma; Phospholipases; Receptors, G-Protein-Coupled; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Tyrosine 3-Monooxygenase | 2022 |
Tocotrienol-Rich Fraction and Levodopa Regulate Proteins Involved in Parkinson's Disease-Associated Pathways in Differentiated Neuroblastoma Cells: Insights from Quantitative Proteomic Analysis.
Topics: Chromatography, Liquid; Humans; Levodopa; Neuroblastoma; Parkinson Disease; Proteomics; Tandem Mass Spectrometry; Tocotrienols; Vitamin E | 2022 |
Modulation of cytotoxic amyloid fibrillation and mitochondrial damage of α-synuclein by catechols mediated conformational changes.
Topics: alpha-Synuclein; Amyloid; Amyloidogenic Proteins; Catechols; Humans; Levodopa; Neuroblastoma; Parkinson Disease | 2023 |
Levodopa (L-DOPA) attenuates endoplasmic reticulum stress response and cell death signaling through DRD2 in SH-SY5Y neuronal cells under α-synuclein-induced toxicity.
Topics: alpha-Synuclein; bcl-2-Associated X Protein; Cell Death; Cell Line, Tumor; CREB-Binding Protein; Disks Large Homolog 4 Protein; Dopamine Agents; Dose-Response Relationship, Drug; Endoplasmic Reticulum Stress; Gene Expression Regulation, Neoplastic; Humans; Iron-Regulatory Proteins; Levodopa; Neuroblastoma; Neurons; NF-kappa B; Receptors, Dopamine D2; RNA, Messenger; Signal Transduction | 2017 |
PARK13 regulates PINK1 and subcellular relocation patterns under oxidative stress in neurons.
Topics: Cell Line, Tumor; Cytoskeleton; Dopamine Agents; Gene Expression Regulation; Humans; Hydrogen Peroxide; Levodopa; Mutation; Neuroblastoma; Neurons; Oxidants; Oxidative Stress; Parkinson Disease; Protein Kinases; RNA, Messenger; Subcellular Fractions; Time Factors; Transfection | 2014 |
Neuroprotective effects of 5-(4-hydroxy-3-dimethoxybenzylidene)-thiazolidinone in MPTP induced Parkinsonism model in mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Animals, Newborn; Benzylidene Compounds; Cells, Cultured; Disease Models, Animal; Levodopa; Male; Membrane Potential, Mitochondrial; Mesencephalon; Mice; Mice, Inbred C57BL; Mitochondria; Mitochondrial Proteins; MPTP Poisoning; Neuroblastoma; Neurons; Neuroprotective Agents; Neurotoxins; Psychomotor Performance; rho GTP-Binding Proteins; Thiazolidinediones; Time Factors; Tyrosine 3-Monooxygenase | 2015 |
L-DOPA therapy interferes with urine catecholamine analysis in children with suspected neuroblastoma: a case series.
Topics: Artifacts; Catecholamines; Child, Preschool; Humans; Infant; Levodopa; Neuroblastoma; Urinalysis | 2017 |
Dopamine and paraquat enhance α-synuclein-induced alterations in membrane conductance.
Topics: alpha-Synuclein; Analysis of Variance; Animals; Cell Line, Tumor; Dopamine; Dopamine Agents; Dopamine Plasma Membrane Transport Proteins; Doxycycline; Drug Interactions; Gene Expression Regulation; Green Fluorescent Proteins; Heme Oxygenase-1; Herbicides; Humans; Levodopa; Membrane Potentials; Mice; Nerve Tissue Proteins; Neuroblastoma; Paraquat; Patch-Clamp Techniques; Permeability; Tetrazolium Salts; Thiazoles; Transfection; Tubulin; Tyrosine 3-Monooxygenase; Vesicular Monoamine Transport Proteins | 2011 |
Acute administration of L-DOPA induces changes in methylation metabolites, reduced protein phosphatase 2A methylation, and hyperphosphorylation of Tau protein in mouse brain.
Topics: Animals; Antiparkinson Agents; Brain; Cell Line, Tumor; Dopaminergic Neurons; Humans; Levodopa; Male; Methylation; Mice; Mice, Inbred C57BL; Nerve Degeneration; Neuroblastoma; Phosphorylation; Primary Cell Culture; Protein Phosphatase 2; tau Proteins | 2012 |
Protective effects of L-dopa and carbidopa combined treatments on human catecholaminergic cells.
Topics: Antiparkinson Agents; Aromatic Amino Acid Decarboxylase Inhibitors; Carbidopa; Cell Line, Tumor; Cell Survival; Comet Assay; DNA Damage; Dopa Decarboxylase; Dopamine; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Humans; Hydrogen Peroxide; Levodopa; Neuroblastoma; Oxidants; Oxidative Stress; Reactive Oxygen Species; Time Factors | 2012 |
Resveratrol attenuates L-DOPA-induced hydrogen peroxide toxicity in neuronal cells.
Topics: Antioxidants; Catechin; Cell Line, Tumor; Cell Survival; Drug Evaluation, Preclinical; Drug Interactions; Fibroblasts; Fluoresceins; Humans; Hydrogen Peroxide; Levodopa; Monoamine Oxidase; Nerve Tissue Proteins; Neuroblastoma; Neurons; Neuroprotective Agents; Oxidative Stress; Quercetin; Resveratrol; Stilbenes; Tyrosine; Tyrosine 3-Monooxygenase | 2012 |
Apoptosis-inducing neurotoxicity of dopamine and its metabolites via reactive quinone generation in neuroblastoma cells.
Topics: Apoptosis; Benzoquinones; Caspase 3; Caspases; Catalase; Catechols; Dopamine; Enzyme Activation; Glutathione; Humans; Hydrogen Peroxide; In Situ Nick-End Labeling; Levodopa; Neuroblastoma; Superoxide Dismutase; Tumor Cells, Cultured | 2003 |
Slowing Parkinson's disease progression: recent dopamine agonist trials.
Topics: Antiparkinson Agents; Benzothiazoles; Biological Transport; Cell Line, Tumor; Clinical Trials as Topic; Dopamine; Dopamine Agonists; Dopamine Plasma Membrane Transport Proteins; Humans; In Vitro Techniques; Indoles; Levodopa; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Neuroblastoma; Parkinson Disease; Pramipexole; Thiazoles | 2004 |
The effect of conventional and sustained delivery of levodopa on SH-SY5Y neuroblastoma cells.
Topics: Antiparkinson Agents; Cell Line, Tumor; Cell Proliferation; Cell Size; Cell Survival; Delayed-Action Preparations; Dose-Response Relationship, Drug; Humans; Levodopa; Neuroblastoma | 2005 |
The effect of conventional and sustained delivery of thymoquinone and levodopa on SH-SY5Y human neuroblastoma cells.
Topics: Antiparkinson Agents; Benzoquinones; Cell Line, Tumor; Cell Survival; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Combinations; Humans; Hydrogen Peroxide; Levodopa; Neuroblastoma; Neuroprotective Agents; Treatment Outcome | 2006 |
Cytosolic catechols inhibit alpha-synuclein aggregation and facilitate the formation of intracellular soluble oligomeric intermediates.
Topics: 3,4-Dihydroxyphenylacetic Acid; alpha-Synuclein; Amino Acid Substitution; Animals; Catechols; Cell Differentiation; Cell Line, Tumor; Cerebral Cortex; Corpus Striatum; Cytosol; Dopamine; Humans; Levodopa; Mice; Mice, Transgenic; Mutation, Missense; Nerve Degeneration; Neuroblastoma; Oxidation-Reduction; Parkinson Disease; Parkinsonian Disorders; Protein Conformation; Recombinant Fusion Proteins; Solubility; Transfection; Tretinoin; Tyrosine 3-Monooxygenase | 2006 |
The mechanism of toxicity of 5-S-cysteinyldopa to tumour cells. Hydrogen peroxide as a mediator of cytotoxicity.
Topics: Animals; Antineoplastic Agents; Cell Line; Cell Survival; Cysteinyldopa; Dihydroxyphenylalanine; Dopamine; Humans; Hydrogen Peroxide; Levodopa; Male; Mice; Neoplasms, Experimental; Neuroblastoma; Oxidation-Reduction | 1983 |
L-dopa inhibits complex IV of the electron transport chain in catecholamine-rich human neuroblastoma NB69 cells.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Ascorbic Acid; Brain; Catecholamines; Electron Transport; Electron Transport Complex IV; Humans; Levodopa; NAD(P)H Dehydrogenase (Quinone); Neuroblastoma; Rats; Tumor Cells, Cultured | 1995 |
Ascorbic acid protects against levodopa-induced neurotoxicity on a catecholamine-rich human neuroblastoma cell line.
Topics: Ascorbic Acid; Brain; Brain Neoplasms; Catecholamines; Cell Line; Drug Interactions; Female; Humans; Levodopa; Male; Neuroblastoma; Parkinson Disease; Quinones; Selegiline | 1993 |
R(-)-deprenyl potentiates dopamine-induced cytotoxicity toward catecholaminergic neuroblastoma SH-SY5Y cells.
Topics: Antioxidants; Dopamine; Drug Synergism; Humans; Levodopa; Monoamine Oxidase Inhibitors; Neuroblastoma; Neuroprotective Agents; Oxidation-Reduction; Oxidative Stress; Pargyline; Propylamines; Reactive Oxygen Species; Selegiline; Tumor Cells, Cultured | 1997 |
Dopamine- and L-beta-3,4-dihydroxyphenylalanine hydrochloride (L-Dopa)-induced cytotoxicity towards catecholaminergic neuroblastoma SH-SY5Y cells. Effects of oxidative stress and antioxidative factors.
Topics: Ascorbic Acid; Catalase; Cell Survival; Deferoxamine; Dopamine; Levodopa; Lipid Peroxidation; Neuroblastoma; Oxidative Stress; Superoxide Dismutase; Tumor Cells, Cultured; Vitamin E | 1997 |
Neuroprotection by pramipexole against dopamine- and levodopa-induced cytotoxicity.
Topics: Animals; Benzothiazoles; Cell Line; Cell Survival; Dopamine; Dopamine Agonists; Dose-Response Relationship, Drug; Glioma; Hybrid Cells; Kinetics; Levodopa; Neuroblastoma; Neuroprotective Agents; Pramipexole; Thiazoles | 1999 |
Ca2+/calmodulin mediated pathways regulate the uptake of L-DOPA in mouse neuroblastoma neuro 2A cells.
Topics: Animals; Biological Transport; Calcium; Calmodulin; Cyclic AMP-Dependent Protein Kinases; Cyclic GMP-Dependent Protein Kinases; Kinetics; Levodopa; Mice; Neuroblastoma; Neurons; Protein Kinase C; Protein Kinases; Tumor Cells, Cultured | 2000 |
L-DOPA and glia-conditioned medium have additive effects on tyrosine hydroxylase expression in human catecholamine-rich neuroblastoma NB69 cells.
Topics: Antioxidants; Apoptosis; Ascorbic Acid; bcl-X Protein; Buthionine Sulfoximine; Carbidopa; Cell Differentiation; Culture Media, Conditioned; Culture Media, Serum-Free; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Enzyme Inhibitors; Glutathione; Humans; Immunoblotting; Immunohistochemistry; In Situ Nick-End Labeling; Levodopa; Neuroblastoma; Neuroglia; Neurons; Proto-Oncogene Proteins c-bcl-2; Time Factors; Tumor Cells, Cultured; Tyrosine 3-Monooxygenase | 2001 |
Determination of some L-3,4-dihydroxyphenylalanine and dopamine metabolites in urine by means of mass fragmentography.
Topics: 3-Methoxy-4-hydroxyphenylethanol; 3,4-Dihydroxyphenylacetic Acid; Adult; Aging; Child; Child, Preschool; Dihydroxyphenylalanine; Dopamine; Flavoring Agents; Gas Chromatography-Mass Spectrometry; Homovanillic Acid; Humans; Infant; Infant, Newborn; Lactates; Levodopa; Middle Aged; Neuroblastoma; Phenylethyl Alcohol | 1978 |
L-Dopa methyl ester: prolongation of survival of neuroblastoma-bearing mice after treatment.
Topics: Animals; Benserazide; Cell Line; Drug Synergism; Leucine; Levodopa; Male; Mice; Neoplasms, Experimental; Neuroblastoma; Thymidine; Uridine | 1978 |
Determination of 3-methoxy-4-hydroxyphenylpyruvic acid, 3,4-dihydroxyphenylethylene glycol, and 3,4-dihydroxyphenylmandelic acid in urine by mass fragmentography, with use of deuterium-labeled internal standards.
Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Catechols; Child; Child, Preschool; Deuterium; Dopamine; Ethylene Glycols; Gas Chromatography-Mass Spectrometry; Humans; Infant; Infant, Newborn; Levodopa; Mandelic Acids; Methoxyhydroxyphenylglycol; Middle Aged; Neuroblastoma; Parkinson Disease; Phenylpyruvic Acids; Pheochromocytoma; Reference Standards; Reference Values; Shock, Cardiogenic | 1978 |
Neurotoxicity of levodopa on catecholamine-rich neurons.
Topics: Catecholamines; Cell Line; Cell Survival; Dopamine; Dose-Response Relationship, Drug; Humans; Levodopa; Neuroblastoma; Neurons; Selegiline | 1992 |
Non-myelotoxic antitumour effects of L-dopa, buthionine sulphoximine and tamoxifen on neuroblastoma cells in vitro and in vivo.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Antineoplastic Agents; Buthionine Sulfoximine; Cell Survival; Cyclic AMP; Glutathione; Humans; Levodopa; Male; Methionine Sulfoximine; Mice; Mice, Nude; Monophenol Monooxygenase; Neuroblastoma; Tamoxifen; Tumor Cells, Cultured | 1991 |
Exogeneous expression of L-dopa and dopamine in various cell lines following transfer of rat and human tyrosine hydroxylase cDNA: grafting in an animal model of Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Disease Models, Animal; DNA; Dopamine; Enzyme Induction; Graft Survival; Levodopa; Male; Neuroblastoma; Parkinson Disease; Rats; Rats, Inbred Strains; Recombinant Fusion Proteins; Transplantation, Heterotopic; Tumor Cells, Cultured; Tyrosine 3-Monooxygenase | 1990 |
Biochemical monitoring of children with neuroblastoma.
Topics: Aminoisobutyric Acids; Child; Cystathionine; Dihydroxyphenylalanine; Homovanillic Acid; Humans; Levodopa; Monitoring, Physiologic; Neuroblastoma; Norepinephrine; Prognosis | 1986 |
Inhibition of human neuroblastoma by dopamine antagonists.
Topics: Animals; Cell Division; Cell Line; Domperidone; Dopamine; Dopamine Antagonists; Female; Humans; Levodopa; Mice; Mice, Nude; Neuroblastoma; Pimozide; Receptors, Dopamine; Spiperone | 1985 |